Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data
Abstract Low-dose computed tomography screening can be used to diagnose lung cancer at a younger age compared to no screening. Real-world studies observing mortality after lung cancer diagnosis are subject to lead-time bias. This study developed a method using a nationwide cancer registry and stage...
Guardado en:
Autores principales: | Szu-Chun Yang, Jung-Der Wang, Shi-Yi Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea58d8495bae47c98e5d171cf56cb00c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon
por: Wu-Wei Lai, et al.
Publicado: (2021) -
Steering law considering biased loads for control moment gyroscopes
por: Yasuyuki NANAMORI, et al.
Publicado: (2015) -
Real-world data analysis of patients with cancer of unknown primary
por: Sora Kang, et al.
Publicado: (2021) -
Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients
por: You-Yi Chen, et al.
Publicado: (2021) -
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy.
por: Emily S Sena, et al.
Publicado: (2010)